References
- Fidler I. J., Nicolson G. L. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor line. J. Natl. Cancer Inst. 1976; 57: 1199
- Heldin C. H., Westermark B., Wasteson A. Platelet-derived growth factor: Purification and partial characterization. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 3722
- Roberts A. B., Anzano M. A., Meyers C. A., Wideman J., Blacher R., Pan Y. E., Stein S., Lehrman S. R., Smith J. M., Lamb L. C., Sporn M. B. Purification and properties of a type β transforming growth factor from bovine kidney. Biochemistry 1983; 22: 5692
- Roberts A. B., Lamb L. C., Newton D. L., Sporn M. B., Delarco J. E., Todaro G. J. Tranforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 3439
- Assoian R. D. Biphasic effects of type β transformling growth factor on epidermal growth factor receptors in NRK fibroblasts. J. Biol. Chen. 1985; 260: 9613
- Peaeistein E., Cooper L. A., Karpatkin S. Extraction and characterization of a platelet-aggregating material from SV 40 transformed mouse 3T3 fibroblasts. J. Lab. Clin. Med. 1979; 93: 332
- Sloane B. F., Dunn J. R., Honn K. V. Lysosomal cathepsin B: Correlation with metastatic potential. Science (Wash., C.) 1981; 212: 1151
- Nicolson G. L. Cancer metastasis: Organ colonization and the cell surface properties of malignant cells. Biochim. Biophys Acta 1982; 695: 113
- Gasic G. L., Gasic T. B., Stewart C. C. Anti-metastatic effects associated with platelet reduction. Proc. Natl. Acad. Sci. U.S.A. 1968; 61: 46
- Honn K. V., Cicone B., Skoff A. Prostacyclin: A potent antimetastatic agent. Science(Wash., D.C.) 1981; 212: 1270
- Shipley G. D., Tucker R. F., Moses H. L. Type β transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval. Proc. Natl. Acad. Sci. U.S.A. 1985; 82: 4147
- Assoian R. K., Frolic C. A., Roberts A. B., Miller D. M., Sporn M. B. Transforming growth factor-β controls receptor levels for epidermal growth factor in NRK fibroblasts. Cell 1984; 36: 35
- Wrann M. M., Fox C. F., Ross R. modulation of epidermal growth factor receptor on 3T3 cells by platelet-derived growth factor. Science(Wash., D.C.) 1980; 210: 1363